Novo Nordisk-Wegovy's prices are going down, but they are ‘wildly different'

Wegovy's prices are going down, but they are ‘wildly different' — and confusing

行业与政策环境 - 患者医疗费用取决于其医疗保险覆盖范围 [1] - 费用还受到日益复杂的联邦政策网络影响 [1] - 公司定价策略是影响患者最终支付成本的关键因素之一 [1]